Thank you, Madam Chair.
I want to thank all of you, obviously. You all come from a range of different fields and have analyzed this.
My first question is for Ms. MacEwen. I want to say that you're very well-informed on this. On behalf of your membership, you made a very broad analysis in a very concise period of time for us.
You've stated that it helps labour rights much more than ever before. I think on biologic drugs it's much better, as you have stated, which will help with future plans for pharmacare. There was some other stuff, I think. I can't quote you on that exactly, but, in terms of pharmacare, it would help, from what you stated.
Have you, your union or other unions like yours been consulted in this much detail with other trade agreements or is this a first? Has it been ongoing?